Safety Assessment of AAV2-hGDNF Administered via Intra-Cerebral Injection in Rats for treatment of Parkinson’s Disease.

od Terse, Pramod S., Kells, Adrian P., Noker, Patricia, Wright, J Fraser, Bankiewicz, Krystof S.
Izdano u Int J Toxicol (2020)

Interspecies pharmacokinetics and in vitro metabolism of SQ109

od Jia, Lee, Noker, Patricia E, Coward, Lori, Gorman, Gregory S, Protopopova, Marina, Tomaszewski, Joseph E
Izdano 2006

Pharmacodynamics and pharmacokinetics of SQ109, a new diamine-based antitubercular drug

od Jia, Lee, Tomaszewski, Joseph E, Hanrahan, Colleen, Coward, Lori, Noker, Patricia, Gorman, Gregory, Nikonenko, Boris, Protopopova, Marina
Izdano 2004

Pharmacokinetics and pharmacodynamics of Phor21-βCG(ala), a lytic peptide conjugate

od Jia, Lee, Noker, Patricia E., Piazza, Gary A., Leuschner, Carola, Hansel, William, Gorman, Gregory S., Coward, Lori U., Tomaszewski, Joseph
Izdano 2008

Toxicology and pharmacokinetics of 1-methyl-[D]-tryptophan: absence of toxicity due to saturating absorption

od Jia, Lee, Schweikart, Karen, Tomaszewski, Joseph, Page, John G., Noker, Patricia E., Buhrow, Sarah A., Reid, Joel M., Ames, Matthew M., Munn, David H.
Izdano 2007

Evaluation of the Safety and Biodistribution of M032, an Attenuated Herpes Simplex Virus Type 1 Expressing hIL-12, After Intracerebral Administration to Aotus Nonhuman Primates

od Roth, Justin C., Cassady, Kevin A., Cody, James J., Parker, Jackie N., Price, Kathleen H., Coleman, Jennifer M., Peggins, James O., Noker, Patricia E., Powers, Nicholas W., Grimes, Sheila D., Carroll, Steven L., Gillespie, G. Yancey, Whitley, Richard J., Markert, James M.
Izdano 2014